AstraZeneca Hit Again With Antitrust Charges

Law360, New York (March 1, 2006, 12:00 AM EST) -- A government service cooperative has charged AstraZeneca with violating U.S. competition law, the latest swipe in a string of suits filed by nearly a dozen unions, pension funds and government agencies accusing the pharmaceutical giant of illegally trying to prevent generic versions of its blockbuster heart drug, Toprol-XL, from entering the marketplace.

The National Joint Powers Association, a self-funded cooperative which supplies goods and services to government agencies, says that Anglo-Swedish AstraZeneca’s illegal monopolization and attempt to monopolize the market for Toprol-XL and its generic versions...
To view the full article, register now.